Personalized Medicine in Cardiovascular and Metabolic Diseases
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: 15 January 2026 | Viewed by 85
Special Issue Editor
2. Department of Molecular Pharmacology, Albert Einstein College of Medicine, New York City, NY 10461, USA
Interests: cardiology; hypertension; restenosis; heart failure; myocardial infarction; endothelial dysfunction; mitochondria; diabetes; microRNAs; insulin resistance; atherosclerosis; thrombosis; cardiac hypertrophy; pancreatic beta cell function; insulin release
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
As the global burden of cardiovascular and metabolic disorders continues to rise, the need for individualized approaches to prevention, diagnosis, and treatment has never been greater. Advances in genomics, multi-omics, imaging, digital health, and biomarker discovery are transforming our understanding of disease mechanisms and enabling tailored interventions that improve outcomes and minimize adverse effects. The Special Issue “Personalized Medicine in Cardiovascular and Metabolic Diseases” aims to highlight cutting-edge research, clinical studies, and technological innovations that drive the development and implementation of personalized medicine in cardiovascular and metabolic care. We welcome original research articles and reviews that explore a wide range of topics, including but not limited to:
- Genomic and epigenomic predictors of cardiovascular and metabolic risk;
- Multi-omics integration for disease stratification and therapeutic targeting;
- AI and machine learning tools in personalized risk assessment and decision-making;
- Novel biomarkers for individualized therapy monitoring;
- Pharmacogenomics and tailored pharmacologic interventions;
- Precision approaches to diabetes, obesity, dyslipidemia, and hypertension;
- Sex-specific and ancestry-informed strategies in cardiometabolic health;
- Personalized prevention and digital therapeutics in population health.
Contributions from interdisciplinary teams that bridge basic science, clinical research, and health informatics are especially encouraged. Submissions should emphasize translational potential, clinical applicability, and future directions in the field. All manuscripts will undergo rigorous peer review and be published open access, ensuring broad visibility and impact. Join us in shaping the future of precision medicine in cardiovascular and metabolic disease care.
Dr. Gaetano Santulli
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiovascular disease
- metabolic syndrome
- precision health
- telemedicine
- biomarkers
- pharmacogenomics
- artificial intelligence
- machine learning
- epigenetics
- diabetes
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
